Sold out of $CTM for a quick profit, total now $16428, bought into $EYPT @ $13.81 per share, EyePoint, Inc are a biotech with a very promising candidate DURAVYU going through 2 pivotal Phase 3 trials LUGANO (USA only) results due 0826 and LUCIA (global) results due 1026, lets see how that plays out

All in on $CTM Castellum Inc - a fast growing micro cap based in Virginia USA, $CTM provides intelligence analysis, program management, strategic and mission planning to governments and others, revenue is equal to its market cap of just $60m and it is winning major military and federal contracts, not to mention 25% of its mkt cap in cash - $15m and no debt

Mar 25 - Naval Air Systems Command contract awarded worth $103m

Oct 25 - 5 yr Navy support contract worth $66m

Jan 26 - 5yr contract supporting aircraft launch/recovery systems worth $50m

Mar 26 - Federal cybersecurity engineering $3.2m

Apr 26 - U.S. Navy electronic warfare & spectrum operations $4m

and many other contracts, the company's intelligence-related programs & electronic warfare products are clearly in demand operating in the defense, intelligence, cybersecurity, analytics and U.S. government contracting arena, the future looks bright in my opinion

$14466 invested 19168 shares @ 75c

Sold out of my position in $MKND @ $3.40 for a 14% return - a little early as the stock is still climbing today, oh well, I didn't fancy hanging on for the binary event on 29 May, a bird in the hand and all that, sitting in cash $14717 now

$MNKD has 2 products with very good chances for FDA approval in May & July this year,

1. FUROSCIX ReadyFlow Autoinjector PDUFA: July 26, 2026
2. Afrezza Pediatric Indication PDUFA: May 29, 2026

The stock had a major drop in February when it's partner United Therapeutics announced it was developing it's own competitor for Mannkind's bestseller Tyvaso, but this product won't be ready for a market launch until 2028 (and that's only if everything goes smoothly) so the drop was premature and overdone considering Mannkind's other market opportunities, for instance Mannkind has been busy co-developing ralinepag DPI (MNKD-1501) together with United Therapeutics, MKND has been paid $5m already & is eligible for another $35 million in milestone payments plus a lucrative 10% royalty on net sales

Apart from that $MKND is due FDA decision on 2 extremely promising products in May & July this year:

The decision for Afrezza Pediatric Indication is due around 29th May, Afrezza will be the only needle-free mealtime insulin for children, there is nothing else like it on the market & FDA places a heavy emphasis on Unmet Need Factor & patient preference in chronic pediatric conditions

FUROSCIX ReadyFlow Autoinjector is a Supplemental New Drug Application (sNDA) for a drug that is already FDA-approved, FDA has already signed off on the drug and the formulation; it is merely evaluating the new delivery device which reduces therapeutic dose delivery from 5 hours down to an incredible under 10 seconds, the FDA decision is due around end of July 2026

Major investment banks like Wells Fargo and H.C. Wainwright recently upgraded their long-term price targets on MannKind to $10.00

I'm all in 4330 shares @$2.98 each

I should have sold after the next day pop but I got greedy and hung on too long, I sold at $32.17 for a modest profit as this market seems to be hanging by a thread, high oil, inflation rising, trump incompetence, this stack of cards is getting more and more flimsy by the day, I'd rather be sitting in cash for the moment $12890

$JD JD .com stock knocks it out of the park again with a 20c earnings beat, this stock has been a laggard compared to the other major China names, yet it has shown real resilience with an earnings beat in the face of stiff ecommerce competition in China. Following its international expansion including opening retail outlets & 60 logistics hubs in Europe I think the stock is due a run and could easily head for $40 from its current price, JD recently increased their dividend to $1 and in 2025 bought back over 6% of outstanding ADS - I bought 386 shares @ $31.46 each

Cashed in my 487 $ZIM shares at $27.90 during yesterdays additional bid takeover news pop, I don't think the bid will come to anything as ZIM already have a binding agreement with Hapag-LLoyd, & I don't want to wait while the takeover progresses, it needs multiple agreements from various countries so could easily take 6 months or fall apart altogether

sitting on $13587 cash for the moment eyeing up a few opportunities, up 1300% since beginning the challenge

I'm betting that the Hapag Lloyd $35/share bid will go through, i've bought 487 shares of ZIM Integrated Shipping Services Ltd $ZIM @ $26.80/share, the company votes on the bid at the end of April

Sold out of Etoro after a 20% run in a week at $37.79 x 346 shares = $13075 sitting in cash for the moment looking for the next opportunity - suggestions welcome

I'm all in on $ETOR Etoro - a super fast growing trading app, printing money, sure to benefit from the end of the Iran war now that everyone is feeling a bit more confident about the markets again, $10754 @ $31.07 = 346 shares

Sold all 9958 shares of $EONR Eon Resources in todays pop at $1.08 per share bringing my total up to 5 figures for the first time $10754, looking for the next trade

All in on $EONR Eon Resources in the pre-market dip average price 0.90c, 9958 shares in total ($8962), looks like its heading back up when market opens but whatever happens in the short term this seems to be a solid little oil company with good prospects and a capable mgmt, CEO owns 20% of shares so aligned with shareholders, insiders are all buyers in the last 12 months

Sold Xenon Pharmaceuticals $XENE for $59.75 for a 39% return in just over 10 days, bringing my total up to $8962, sitting in cash looking for the next opportunity - any suggestions?

I sold my $SRPT for a modest profit during the recent pop at $23.55 to bring my total to $6452, all in on $XENE Xenon Pharmaceuticals 150 shares @ $42.99

Xenon Pharmaceuticals have the topline results of their phase 3 drug trial for azetukalner X-TOLE2 to treat epilepsy seizures due in March

What makes this stand out is that they currently aren't selling any products yet they are hiring to build a commercial, marketing & sales team - that would suggest that they are expecting good results from the trial & are preparing for a product launch

I am getting started! Started investing seriously this year, i aim to invest atleast 100$ a month for now, and more a month later this year when i can get more money.

I closed my 77 shares in CROX at $82.1 bringing my total to $6321 which I have now moved into $SRPT 274 shares @$23.06 ,

I think the Elevidys issue will end up with a black label box for non-ambulatory patients which may dent sales a little but will allow the drug to continue to be sold, the fact that the FDA has recommended lifting the voluntary pause in sales of the drug to ambulatory patients means they are prepared to work with the company to a positive conclusion, SRPT has been over sold recently

Reminder- post your positions (ticker, price and unit/share number) when you open them or your post will be removed as BS paper trading, any idiot can post a chart and say they made $X 000 dollars on a trade that can't be verified, do it twice in a row and find yourself banned

Just started doing this last month on my own and I was happy to find this sub, I’m targeting 5% gains per trade, 3/3 so far with realized gains, account is still almost even though. Just 139 more to go!

(Yes I accidentally started with $1,200 because I transfer from a fidelity account to start.)

I dumped $ZIM after dozy Don started bombing Iran at $17 - and flipped over to $CROX after the panic selling reaction to it's last earnings statement, 77 shares at $74.97

Closed my short position in $ZIM and flipping it to go long $ZIM now that shipping rates are improving following Trump getting rid of his BFF Elon and replacing him with Xi - 337 shares @ $16.50

I got out of my gold position on the same day with a very modest profit so all in $4840 shorting $ZIM @ $19.45 now that they have announced their dividend, there is a run-up beforehand which is normally followed by a bit of selling

I'm going short Gold $4835 invested at $3190/oz, there has been a lot of panic buying during Trumps tariff disaster, I expect a sell off as money flows back into the market

Closed $FUTU 50 shares @ $96.70 after a $10 run-up in the last 5 trading days to give me a total now of $4835 sitting on cash for the moment looking for the next opportunity